Remdesivir: The National Institute of Allergy & Infectious Diseases (NIAID) reported that its clinical trial of remdesivir showed that "patients receiving remdesivir had a 31% faster time to recovery than the placebo group" (this is a preliminary finding). These were all in very sick, hospitalized patients.
Answered 6/14/2020
69 views
3 doctors weighed in across 2 answers
2 doctors weighed in across 2 answers
4 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question